Cyclohexyl Sodium Cyclamate Market is expected to grow exponentially in forecast period 2018- 2025 key players …

A new research study from HTF MI with title Global Cyclohexyl Sodium Cyclamate Market Insights, Forecast to 2025 provides an in-depth assessment of the Cyclohexyl Sodium Cyclamate including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Cyclohexyl Sodium Cyclamate investments till 2022. Access Sample Copy […]

FDA recalls thyroid medication

FDA recalls thyroid medication

The Food and Drug Administration has issued a voluntary recall for a thyroid medication made by a Chinese manufacturer because of potential problems with an ingredient. In the Aug. 9 statement, the FDA said Levothyroxine and Liothyronine 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg thyroid tablets are being recalled as a precaution. […]

Five things for pharma marketers to know: Wednesday, August 15, 2018

Five things for pharma marketers to know: Wednesday, August 15, 2018

ViiV’s long-acting HIV injection has proven to be as effective as daily pills at controlling AIDS, according to the company. The injection of two drugs is administered monthly, as opposed to treatments that require three pills taken daily. GSK, the majority owner of ViiV, hopes the drug will help it better compete with Gilead, which […]

US FDA grants Breakthrough Therapy Designation for food allergy drug Xolair

US FDA grants Breakthrough Therapy Designation for food allergy drug Xolair

Xolair (omalizumab), a therapy for the prevention of severe food allergy reactions after accidental exposure, was granted a Breakthrough Therapy Designation​ by the US Food and Drug Administration (FDA). The drug is part of Genentech’s portfolio, which now has twenty-three medicines with Breakthrough Therapy Designation. Currently, there are no preventative treatments for severe food allergies. […]

Judge Rules that Weed Killer Caused Cancer in Terminally Ill Man — Here's How to Limit Your Exposure

Judge Rules that Weed Killer Caused Cancer in Terminally Ill Man — Here's How to Limit Your Exposure

In a groundbreaking decision, a terminally ill California man won a $289 million settlement on Friday from the controversial chemical manufacturer Monsanto after a judge agreed that the company’s weed killer, Roundup, caused the man’s cancer. The lawsuit opens the floodgates for more litigation against Monsanto — which denies that the weed killer causes cancer […]

J&J, ViiV tout positive data for two-drug HIV therapy

J&J, ViiV tout positive data for two-drug HIV therapy

Dive Brief: A long-acting HIV therapy from Johnson & Johnson and ViiV Healthcare has shown similar efficacy to a standard of care regimen, according to topline Phase 3 data announced Wednesday. The ATLAS study tested whether an injectable therapy that combined ViiV’s cabotegravir, an investigational analog of the blockbuster HIV drug dolutegravir, with rilpivirine, the […]

FTC Weighs In On Biosimilar Competition

FTC Weighs In On Biosimilar Competition

In the FDA’s Biosimilar Action Plan, the agency indicated that it seeks to partner more closely with the Federal Trade Commission (FTC) to help remove barriers to competition that are not directly within the FDA’s control. However, in recent comments to HHS, the FTC is calling on the FDA to use its own authority to […]

Innovation and collaboration: key catalysts for scientific break-throughs

Innovation and collaboration: key catalysts for scientific break-throughs

During my time at Illumina I had a realisation: restricted access to data, and an industry-wide aversion to collaboration, was delaying and in some instances preventing the discovery of treatments and cures for cancer, as well as consistently hampering progress and innovation across biomedical research. Even publicly available data for research, which is growing at […]

Novel Drug May Help Reduce Tumor Growth, Slow Progression of Liver Cancer

Novel Drug May Help Reduce Tumor Growth, Slow Progression of Liver Cancer

Hepatocellular carcinoma (HCC) accounts for more than 90% of all liver cancers. Because of its limited treatment options and poor prognosis, there is currently an unmet need for alternative, more effective therapies. In a new study, researchers have developed a novel peptide drug called FFW that could potentially reduce tumor growth and slow progression of […]

Group purchasing organization builds cloud-based, AI-powered precision medicine app

Group purchasing organization builds cloud-based, AI-powered precision medicine app

Growth of the artificial intelligence market for healthcare is expected to reach $6.6 billion by 2021, according to Accenture, and the combined deployment of key clinical health AI applications could potentially create $150 billion in annual savings for the U.S. healthcare economy by 2026. In line with that growing trend, Rockville Centre, New York-based Precision […]